Singapore To Make Major Medtech Regulatory Changes Under Economic Growth Plan
Executive Summary
Regulatory and market access improvements for medtech products were on the agenda at last month's Health Products Regulatory Forum in Singapore. These forward-looking changes are seen by the government and the Health Sciences Authority (HSA) as the medtech sector's contribution to initiatives and aims developed by the Singapore Committee on the Future Economy (CFE).
You may also be interested in...
Singapore & Beyond: Asian Medtech Associations Regulatory Networking November 2017, Part 2
In the second of two Asian Medtech Associations Regulatory Networking discussions this month, we focus on regulatory reforms in Singapore, and updates on Indonesia, the Philippines and Vietnam from recent regional regulatory meetings. This series is hosted by Medtech Insight and sponsored by the Asia Regulatory and Quality Consultancy (ARQon), the Asia Regulatory Professionals Association (ARPA), and Medtronic.
Medtech Associations Regulatory Networking, July 2017 – Singapore, the Philippines, Myanmar
The first Medtech Associations Regulatory Networking discussion, hosted by Medtech Insight and sponsored by the ARQon consultancy (Singapore) and the Asia Regulatory Professionals Association (ARPA), was held in mid-July. Updates were received from senior regulatory figures in three Asian medtech markets where regulation is evolving fast – Singapore, the Philippines and Myanmar.
Asia Reg Roundup: Cybersecurity, China, ASEAN And MDSAP Updates
China is making additions to its medtech regulatory system, and Southeast Asian nations are making progress towards ratifying the regional Medical Device Directive. Meanwhile, cybersecurity, priority reviews and the Medical Device Single Audit Program are demanding attention regionally and globally, as ARQon consultant May Ng and Asia Regulatory Professional Association (ARPA) secretary Jack Wong report in this Asian regulatory update.